Soros Fund Management LLC Sells 50,000 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Soros Fund Management LLC trimmed its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 6.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 700,000 shares of the company’s stock after selling 50,000 shares during the quarter. Soros Fund Management LLC’s holdings in Privia Health Group were worth $13,685,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Barclays PLC grew its position in Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after buying an additional 158,188 shares in the last quarter. Virtu Financial LLC bought a new stake in shares of Privia Health Group during the 3rd quarter valued at $263,000. Franklin Resources Inc. boosted its stake in Privia Health Group by 2.2% in the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after purchasing an additional 28,480 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Privia Health Group by 8.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock worth $3,430,000 after purchasing an additional 14,641 shares in the last quarter. Finally, Nordea Investment Management AB boosted its stake in Privia Health Group by 33.1% in the 4th quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock worth $6,953,000 after purchasing an additional 86,910 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on PRVA shares. Canaccord Genuity Group upped their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. Truist Financial boosted their target price on Privia Health Group from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Thursday, April 10th. Needham & Company LLC reissued a “buy” rating and issued a $30.00 target price on shares of Privia Health Group in a research report on Thursday, April 10th. Barclays boosted their target price on Privia Health Group from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 10th. Finally, Robert W. Baird increased their price objective on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 15th. One research analyst has rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $27.14.

Insider Activity at Privia Health Group

In related news, CFO David Mountcastle sold 5,630 shares of the company’s stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the transaction, the chief financial officer now directly owns 179,676 shares in the company, valued at approximately $4,021,148.88. This represents a 3.04 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 10.70% of the stock is currently owned by insiders.

Privia Health Group Stock Up 0.1 %

Privia Health Group stock opened at $23.20 on Tuesday. The company has a market cap of $2.81 billion, a PE ratio of 232.02, a price-to-earnings-growth ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $26.04. The company’s 50-day moving average price is $23.60 and its 200-day moving average price is $21.97.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.